Quick Takeaways
- JPMORGAN CHASE & CO filed SCHEDULE 13G/A for REGENXBIO Inc. Common Stock, par value $0.0001 per share (RGNX).
- Disclosed ownership: 7.4%.
- Date of event: 31 Dec 2024.
JPMORGAN CHASE & CO - 31 Dec 2024 SCHEDULE 13G/A Report for REGENXBIO Inc. Common Stock, par value $0.0001 per share (RGNX)
- Filing Manager
- JPMORGAN CHASE & CO
- Reporting Manager
- JPMORGAN CHASE & CO.
- Symbol
- RGNX
- Shares outstanding
- 49,984,622 shares
- Disclosed Ownership
- 3,698,862 shares
- Ownership
- 7.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2025, 15:07:21 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"JPMORGAN CHASE & CO disclosed 7.4% ownership in REGENXBIO Inc. Common Stock, par value $0.0001 per share (RGNX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2025, 15:07.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO. | 7.4% | 3,698,862 | 3,405,254 | 0 | Rachel Tsvaygoft | Vice President |